Prosecution Insights
Prosecution Insights
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (80%) |
| §112 only | 1 (20%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| DENT, ALANA HARRIS | 1 | 44.6% | +32.4% |
| REDDIG, PETER J | 1 | 58.0% | +40.0% |
| BORI, IBRAHIM D | 1 | 43.1% | +38.0% |
| KONOPELSKI SNAVEL, SARA ELIZABETH | 1 | 33.3% | +30.0% |
| HENSEL, BRENDAN A | 1 | 66.9% | +29.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17775791 | COBICISTAT FOR PREVENTION AND/OR TREATMENT OF CORONAVIRUS INFECTIONS | REDDIG, PETER J | 147d overdue |
| 17107099 | COMBINATION THERAPY OF LYMPHOMA | BORI, IBRAHIM D | 99d overdue |
| 18578142 | Xenon Gas for Use in the Treatment of Gliomas | DENT, ALANA HARRIS | 52d overdue |
| 16959516 | PHOTOBIOMODULATION DEVICE | HENSEL, BRENDAN A | 26d overdue |
| 17051123 | MODIFIED AAV CAPSID POLYPEPTIDES FOR TREATMENT OF MUSCULAR DISEASES | KONOPELSKI SNAVEL, SARA ELIZABETH | 35d |
| Art Unit | Apps |
|---|---|
| 1643 | 1 |
| 1646 | 1 |
| 1629 | 1 |
| 1658 | 1 |
| 1758 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18578142 | Xenon Gas for Use in the Treatment of Gliomas | DENT, ALANA HARRIS | 1643 | §103 | Non-Final OA | 52d overdue | Pending | Jan 10, 2024 |
| 17775791 | COBICISTAT FOR PREVENTION AND/OR TREATMENT OF CORONAVIRUS INFECTIONS | REDDIG, PETER J | 1646 | §103 | Final Rejection | 147d overdue | Pending | May 10, 2022 |
| 17107099 | COMBINATION THERAPY OF LYMPHOMA | BORI, IBRAHIM D | 1629 | §103 | Final Rejection | 99d overdue | Pending | Nov 30, 2020 |
| 17051123 | MODIFIED AAV CAPSID POLYPEPTIDES FOR TREATMENT OF MUSCULAR DISEASES | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | §112 | Non-Final OA | 35d | Pending | Oct 27, 2020 |
| 16959516 | PHOTOBIOMODULATION DEVICE | HENSEL, BRENDAN A | 1758 | §103 | Final Rejection | 26d overdue | Pending | Jul 01, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial